Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast and ovarian cancer that are so high and seem so selective that many mutation carriers choose to have prophylactic surgery. There has been much conjecture to explain such apparently striking tissue specificity. All these suggestions share the assumption that some disabled function of normal tumor suppressor genes leads to a tissue specific cancer response. Here the idea is proposed and tested that major determinants of where BRCA1/2 hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation or the carcinogen. The target tissue may have receptors for the pathogen, become selectively exposed to an inflammatory process or to a carcinogen such as during digestion, metabolism or elimination. An innate genomic deficit in a tumor suppressor gene impairs normal responses to these extrinsic challenges and exacerbates the susceptibility to disease in organ targets. This hypothesis also fits data for several tumor suppressors beyond BRCA1/2. A major advantage of this model is that it suggests there may be some options in addition to prophylactic surgery.
Introduction
Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast / ovarian cancer that are so high and apparently so selective that many mutation carriers choose to have prophylactic surgery. Rebbeck et al. (2009) , King et al. (2003) . This raises the question why cancer just attacks breasts and ovaries when every cell with a nucleus inherits the same mutation. Functionally, both BRCA genes are general cell requirements because they encode products essential for fundamental activities such as DNA repair. Why does inheriting a defect in general cell requirements lead to cancers in specific target organs? Answering these questions might help delay or prevent the onset of hereditary cancers.
One plausible explanation involves the high proliferative activity in ovary and breast tissues, especially when under the influence of estrogens. (Welcsh and King, 2001) . Cells with an inherited deficit in BRCA1 or BRCA2 acquire a second mutation spontaneously in these tissues. Mutations in BRCA1 and BRCA2 genes may be more likely because of high frequencies of repetitive elements. (Welcsh and King, 2001 ). Cells with mutations in both alleles then become repair deficient and acquire additional muta- Most grossly abnormal cells die, but in rapidly proliferating breast epithelium some abnormal cells escape by acquiring critical checkpoint mutations. These cells may give rise to cancers. One objection to this explanation is that other tissues and cells also have high proliferation rates but are not generally regarded as specific sites for tumor formation in BRCA1/2 mutation carriers. However, implicating BRCA1/2 and associated genes in lymphomas and leukemias does suggest that prolonged high proliferation rates may contribute (Friedenson, 2007) .
The predilection of BRCA1 carriers to develop cancers in breast and ovary suggests tissue specific activities that may be due in part to tissue specific transcription functions. While it has not been demonstrated that BRCA1 can interact directly with a sequence within undamaged DNA, BRCA1 can bind to various sequence-specific DNA binding transcription factors to alter transcription. Rosen et al. (2006) .
It is possible that BRCA1 may regulate certain genes expressed only in the breast and ovaries. The altered expression of these transcripts would lead to an increase in neoplastic transformation. (Welcsh and King, 2001 ). However, risks for other cancers in may play an inhibitory role in estrogen receptor (ER) signaling that could help explain the tissue specificity. et al. (2001) , (Dizin and Imminger-Finger, 2010 
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Materials and Methods
Test models for cancers with known relationships to pathogens or carcinogens. (Fig. 1) . 1300 articles published in the past 50 years were retrieved and copied to a database to facilitate computer searching and review.
Many bibliographies were also reviewed for additional relevant references that may have been missed. Explicit procedures were used to systematically identify, appraise, summarize and statistically aggregate relevant studies. Moher et al. (1999) .
Statistical analyses. For meta-analyses, the random effects model was used (Dersimonian and Laird, 1986) . P values were derived from two-sided statistical tests.
Results and Discussion
Evidence for interactions between infections or a carcinogen linked to cancers and FA, BRCA1/2, and ATM. A composite model ( Cohn and D'Andrea, 2008) , (Whitby, 2010 A-T and FA patients also have strong risk factors for viral hepatitis (and liver cancer) because they require multiple transfusions. FA-C deficiency has been shown to confer an unusually high susceptibility to viral transformation. Liu et al. (1996) . Ashkenazi Jews (a group with a high incidence of BRCA1/2 and FA mutations) also seem unduly susceptible to HCV transmission and infectivity. Golan et al. (1996) .
Mechanisms of DNA damage due
to infections / inflammation suggest repair is required but infections may inhibit repairs.
Infection and inflammation of many tissues accompany
upregulation of an inducible nitric oxide synthase that can produce excess nitric oxide for a prolonged period. Nitric oxide derived reactive species cause DNA damage and have carcinogenic potential (Sawa and Ohshima, 2006) . A mutated BRCA1 gene was detected in 13/17 precancerous lesions of the cervix. Park et al (1999) . is required for double strand break repair by homologous recombination. ATM is probably essential for rapid phosphorylation of Exo1. In turn Exo1 phosphorylation is essential to recruit Rad51. Phosphorylation of Exo1 by ATM is dispensable for resecting double strand breaks but this likely interferes with homologous recombination due to defective loading of Rad51. Bolderson et al. (2010) . ATM also induces a cell cycle checkpoint and phosphorylates BRCA1 and FANCD2. FA core complex proteins cause the ubiquitylation of FANCD2 which is then found in repair foci along with BRCA1 and BRCA2. FANCD2 might antagonize Ku70 activity and divert double-strand break repair away from abortive NHEJ and toward homologous recombination. Pace et al (2010) .
One member of the FA core complex, FA-M is a DNA junction-specific helicase / translocase that targets and processes perturbed replication forks and intermediates of homologous recombination. (Whitby, 2010 ), Gari et al. (2008 . Acetaldehyde from alcohol metabolism and inflammation also induce interstrand cross-links which characteristically require pathway components for repair. BRCA1 is essential to form nuclear foci, believed to be sites of DNA repair. BRCA2 aids the recruitment and loading of the RAD51 repair protein onto processed double strand breaks. ATR, a kinase closely related to ATM is activated later when stalled replication forks form during replication of damaged DNA. Bolderson et al. (2010) . The ATR signaling cascade re-enforces ATMinduced cell cycle checkpoints.
Cancer risks for FA were measured before all the components were known and refer to FA genes as a group. Not shown are numerous interactions involving BRCA1 or BRCA2 with other proteins, details of relationships to cell cycle checkpoints, and to estrogen signaling. The drawing represents a working model that may actually represent the sum of simultaneous pathways activated in response to complex inflammation or acetaldehyde related DNA damage, requiring several different types of repair. Inflammation also causes damage requiring other pathways for repair such as mismatch repair, base excision repair, etc. methylation was found in about 30% of 91 cervical cancers. Woodman et al. (2007) . Infection with HPV activates the ATM-Chk2 checkpoint pathway (Fig. 1) . This permits repair of damage by homologous recombination (Fig 1) this damage results in a concentration-dependent increase in FA-D2 mono-ubiquitylation, which is dependent upon the FA core complex (Fig. 1) . The acetaldehyde DNA damage response is qualitatively similar to the cellular response to mitomycin C, the classic test for deficiencies in FA. Marietta et al (2009) . Alcohol also causes oxidative stress, endoplasmic reticulum stress, and inflammatory / immune responses. 
Other cancers with probable links
to inflammation strongly correlate with biallelic BRCA2 mutation. In carriers of compound BRCA2 mutations, risks for other cancers associated with chronic infections and inflammation are very strongly linked to the presence of the mutation.
Acute myeloid leukemias of the monocytic lineage can be induced reproducibly and with high incidence due to collaborative effects from severe chronic inflammation and infection by specific retroviruses. Wolff et al. (1991) . In 6 children with biallelic BRCA2 mutations, leukemia occurred in all 6 at a median age of 2.2 years, with 4 of the 6 developing acute myeloid leukemia. Solid tumors with links to inflammation are also extraordinarily frequent. Of 14 patients with biallelic BRCA2 mutations, 5 died of early onset brain tumors, primarily medulloblastomas, and 3 developed Wilms tumors. Wagner et al. (2004) . These are all cancers with known links to chronic infection/inflammation. In a formal review of biallelic BRCA2 mutation patients, Alter et al. (2007) similarly found dramatic risks for specific cancers with strong associations to inflammation. Cumulative probability of leukemia (primarily AML) was 79% by age 10 years, that of a solid tumor was 83% by age 6.7 years, that of a brain tumor (primarily medulloblastoma) was 85% by age 9 years, that of a Wilms tumor was 63% by age 6.7 years. Other studies conflict but Thompson et al. (2002) found enough "digestive tract cancers" or unknown primary cancers to significantly change reported risks for colorectal cancers. Colorectal cancer is a common cause for primary cancers with unknown origin.
Hereditary colon cancer may involve
Based on a small study, a chromosomal marker near the BRCA1 gene may be a useful marker for identifying genetic instability in ulcerative colitis lesions leading to neoplastic development. Matsumoto et al.
(2003).
These difficulties give added importance to colon cancer models that can test for the involve- Involvement of APC in the surveillance mechanism of accurate mitosis has been proposed. Abal et al. (2007) . Table   1 shows RR data from FA, BRCA1/2 and ATM mutation carriers for five organ specific cancers with wellknown associations with chronic infection/ inflammation -cancer of the liver, cervix, vulva, head and neck area, and stomach. For these cancers, the pathogen is an important factor in determining which cancer occurs. Table 1 show that a deleterious mutation in BRCA1, BRCA2 or ATM genes greatly increases risks for cancers known to be linked to chronic infection.
There are strong precedents for the idea that the same process can be inactivated at multiple points.
Cancer genome sequences show that more than one mutation within the same pathway is unusual (Vogelstein and Kinzler, 2004) . Other processes such as mismatch repair that depend on multiple genes can be et al (2003) . Cancers associated with BRCA1 mutations had more lymphocytic infiltration than sporadic , control cancers. Lakhani et al (1998) , Adem et al (2003) , (Lakhani, 1999) and a higher expression of lymphocyte specific genes on microarray analysis. van't Veer et al (2002) . Medullary cancer is more frequent in BRCA1/2 mutation carriers and is also closely associated with a dense lymphocyte infiltrate. Kuroda et al. (2005) . at greater risk for BRCA1/2 mutations but not in controls. Wang-Johanning et al. (2008) . BRCA1/2 status was not determined but most breast cancers occurred in younger age patients (ages <=55 and < 50). Wang-Johanning et al. (2008) . RNA expression from 
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Conclusion
Mutations in BRCA1/2 genes and other hereditary mutations increase cancer risks from chronic infection, inflammation, pathogens and at least one carcinogen which contribute to selecting the site where hereditary cancer develops. This information may be useful to prevent or delay cancers in mutation carriers.
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There are no relationships that could result in bias or conflict of interest. Heterogeneity testing (as I 2 or between study variance) evaluated whether the effect size in different subgroups (defined biologically or medically) varied significantly from the main effect. An IStomach cancer may be underestimated in BRCA1 carriers significant numbers of "abdomen not otherwise specified" as well as peritoneal, and intestinal tract cancers were reported Thompson et al (2002 (2007) . The one study that specifically reported oropharyngeal cancer also found the highest RR. Evans et al. (2001) .
Details of these calculations have been reported elsewhere (Friedenson, accepted for publication, 2010). Briefly, cohorts in the table had a documented mutation in the family and/or numerous breast or other cancers at age <60. Inherited defects were in FA proteins, BRCA1, BRCA2 or the upstream activator ATM. Studies of groups having a known probability of carrying a mutation <25% (3 studies) were excluded. Other exclusion criteria were > 20% of subjects lost due to mortality, illness, refusal to participate, missing information, lost branches of family trees, dropouts, etc. or some other preselection such as ignoring family branches likely to have cancer (7 studies). Any of these criteria would potentially weight results for cancer survivors or people who never get cancer. (Friedenson 2009) . No assumptions were made about the risk for a cancer at any individual site unless the study reported incidence at the site.
In order to qualify for inclusion, a study had to meet the following a priori criteria of quality. The study had to (1) have sufficient follow-up (1-10 years) (2) include incidence data from >100 individuals for cancers beyond breast and ovarian cancer, (3) have a probability of mutation >=25%, assuming a positive family history (4) provide relative risks for cancers beyond breast and ovarian, with confidence intervals (CIs) or sufficient data to allow calculation of RRs and CIs. A standard protocol was followed to extract data from each included study.
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